Search Within

Roni Tamari

Formats
  1. Meeting Abstract (124)
  2. Journal Article (75)
  3. Research Letter (7)
  4. Review (6)
  5. Book Section (1)
Groups
  1. Bone Marrow Transplant (213)
  2. CTCR Scholars (213)
  3. Center for Hematologic Malignancies (213)
  4. Department of Medicine (213)
  5. Hematologic Malignancies, Division of (213)
  6. MSK Grad Students (213)

More Groups

People
  1. Sergio Giralt (160)
  2. Miguel-Angel Perales (140)
  3. Ann Jakubowski (123)
  4. Esperanza Papadopoulos (120)
  5. Sean Devlin (99)
  6. Brian Shaffer (88)

More People

Years
  1. 2025 (4)
  2. 2024 (10)
  3. 2023 (22)
  4. 2022 (26)
  5. 2021 (23)
  6. 2020 (28)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (68)
  2. Blood (54)
  3. Bone Marrow Transplantation (24)
  4. Transplantation and Cellular Therapy (17)
  5. Blood Advances (12)
  6. Journal of Clinical Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (87)
  2. American Society of Hematology (66)
  3. Nature Publishing Group (26)
  4. American Society of Clinical Oncology (4)
  5. Oxford University Press (4)
  6. American Society for Clinical Investigation (3)

More Publishers

Results (213)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes and management of SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation (HCT) and CAR-T therapy
    Meeting Abstract

    Infante, M. S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Politikos, I.; Barker, J. N.; Babady, N. E.; Ramanathan, L.; Seo, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Racial disparities in access to alternative donor allografts persist in the era of "donors for all"
    Research Letter

    Fingrut, W. B.; Gyurkocza, B.; Davis, E.; Flynn, J.; Chinapen, S.; Naputo, K. A.; Quach, S.; Cho, C.; Giralt, S. A.; Jakubowski, A. A.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Eprenetapopt plus azacitidine after allogeneic hematopoietic stem-cell transplantation for TP53 -mutant acute myeloid leukemia and myelodysplastic syndromes
    Journal Article

    Mishra, A.; Tamari, R.; DeZern, A. E.; Byrne, M. T.; Gooptu, M.; Chen, Y. B.; Deeg, H. J.; Sallman, D.; Gallacher, P.; Wennborg, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era
    Research Letter

    Vaughn, J. L.; Brown, S.; Papadopoulos, E. B.; Jakubowski, A. A.; Tamari, R.; Giralt, S. A.; Ponce, D. M.; Cho, C.; Perales, M. A.; Shaffer, B. C.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Impact of letermovir primary cytomegalovirus prophylaxis on 1-year mortality after allogeneic hematopoietic cell transplantation: A retrospective cohort study
    Journal Article

    Su, Y.; Stern, A.; Karantoni, E.; Nawar, T.; Han, G.; Zavras, P.; Dumke, H.; Cho, C.; Tamari, R.; Shaffer, B.; more...
    Clinical Infectious Diseases (2022)

    Fulltext@MSK | Save
  • Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: A multicenter study
    Journal Article

    Kunte, S.; Rybicki, L.; Viswabandya, A.; Tamari, R.; Bashey, A.; Keyzner, A.; Iqbal, M.; Grunwald, M. R.; Dholaria, B.; Elmariah, H.; more...
    Leukemia (2022)

    Fulltext@MSK | Save
  • Daratumumab salvage therapy for refractory immune cytopenias after ALLOHCT
    Meeting Abstract

    Lin, A.; DeRespiris, L.; Chinapen, S.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Lin, R. J.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Prolonged post-transplant ruxolitinib therapy is associated with protection from severe gvhd after allogeneic HCT
    Meeting Abstract

    DeFilipp, Z.; Kim, H. T.; Knight, L.; Kelley, D.; Byrne, M. T.; Schroeder, M. A.; Tamari, R.; Wall, S. A.; Vasu, S.; Abedin, S.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Humoral response to COVID-19 vaccination given pre-cellular therapy wanes in patients after cellular therapy: An argument for full reimmunization
    Meeting Abstract

    Shah, G. L.; Chung, D. J.; Tamari, R.; Politikos, I.; Jakubowski, A. A.; Marcello, L.; Doddi, S.; Ramanathan, L.; Pessin, M.; Palazzo, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save